Future studies on the potential of IL-8 in predicting the response to different HCC therapies and on the specific role of IL-8 in HCC pathogenesis are needed to further define its potential role as a decision aid for the management of patients with HCC. This evidence concerns the gene CXCL8 and hepatocellular carcinoma.